Pharmacological inhibition of polysialyltransferase ST8SiaII modulates tumour cell migration

Al-Saraireh, Y, Sutherland, M, Springett, B, Freiberger, F, Ribeiro Morais, G, Loadman, P, Errington, Rachel ORCID: https://orcid.org/0000-0002-8016-4376, Smith, Paul, Fukuda, M, Gerardy-Schahn, R, Patterson, L, Shnyder, S and Falconer, R 2013. Pharmacological inhibition of polysialyltransferase ST8SiaII modulates tumour cell migration. PLoS ONE 8 (8) , e73366. 10.1371/journal.pone.0073366

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (1MB) | Preview

Abstract

Polysialic acid (polySia), an α-2,8-glycosidically linked polymer of sialic acid, is a developmentally regulated post-translational modification predominantly found on NCAM (neuronal cell adhesion molecule). Whilst high levels are expressed during development, peripheral adult organs do not express polySia-NCAM. However, tumours of neural crest-origin re-express polySia-NCAM: its occurrence correlates with aggressive and invasive disease and poor clinical prognosis in different cancer types, notably including small cell lung cancer (SCLC), pancreatic cancer and neuroblastoma. In neuronal development, polySia-NCAM biosynthesis is catalysed by two polysialyltransferases, ST8SiaII and ST8SiaIV, but it is ST8SiaII that is the prominent enzyme in tumours. The aim of this study was to determine the effect of ST8SiaII inhibition by a small molecule on tumour cell migration, utilising cytidine monophosphate (CMP) as a tool compound. Using immunoblotting we showed that CMP reduced ST8iaII-mediated polysialylation of NCAM. Utilizing a novel HPLC-based assay to quantify polysialylation of a fluorescent acceptor (DMB-DP3), we demonstrated that CMP is a competitive inhibitor of ST8SiaII (K i = 10 µM). Importantly, we have shown that CMP causes a concentration-dependent reduction in tumour cell-surface polySia expression, with an absence of toxicity. When ST8SiaII-expressing tumour cells (SH-SY5Y and C6-STX) were evaluated in 2D cell migration assays, ST8SiaII inhibition led to significant reductions in migration, while CMP had no effect on cells not expressing ST8SiaII (DLD-1 and C6-WT). The study demonstrates for the first time that a polysialyltransferase inhibitor can modulate migration in ST8SiaII-expressing tumour cells. We conclude that ST8SiaII can be considered a druggable target with the potential for interfering with a critical mechanism in tumour cell dissemination in metastatic cancers

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > R Medicine (General)
Uncontrolled Keywords:	Binding, Competitive;Cell Line, Tumor;Cell Movement/drug effects*;Cell Proliferation/drug effects;Chromatography, High Pressure Liquid;Cytidine Monophosphate/pharmacology*;Dose-Response Relationship, Drug;Enzyme Inhibitors/pharmacology*;Gene Expression;Humans; Kinetics;Neural Cell Adhesion Molecules/genetics;Neural Cell Adhesion Molecules/metabolism*;Organ Specificity;Protein Binding;Sialyltransferases/antagonists & inhibitors*;Sialyltransferases/genetics;Sialyltransferases/metabolism
Publisher:	Public Library of Science
ISSN:	1932-6203
Date of First Compliant Deposit:	10 April 2018
Date of Acceptance:	18 July 2013
Last Modified:	04 May 2023 23:09
URI:	https://orca.cardiff.ac.uk/id/eprint/110504

Citation Data

Cited 38 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item